Chairman, President & CEO
Dr. Weidong Yin has served as the chairman, president and chief executive officer of Sinovac Biotech Ltd. since September 2003. Dr. Yin is also the Company’s general manager and secretary as well as the chairman of Sinovac Hong Kong, Tangshan Yian and Sinovac Dalian. Before joining Sinovac, Dr. Yin served as the general manager of Tangshan Yian Bioengineering Co., Ltd. Prior to that, he worked as an infectious disease specialist at the China Center for Disease Control and Prevention inTangshan City, Hebei Province. Dr. Yin has been dedicated to hepatitis research for over 20 years and was instrumental in the development of the Company’s Healive vaccine. In addition, Dr. Yin has been appointed principal investigator by the Chinese Ministry of Science and Technology for many key government R&D programs for vaccines such as inactivated hepatitis A vaccine, inactivated SARS vaccine and H5N1 vaccine. Dr. Yin obtained his MBA from the National University of Singapore and his medical degree from Tangshan Medical School.